PCN5- DOCETAXEL/DOXORRUBICIN (DD) AS FIRST LINE CHEMOTHERAPY- QUALITY OF LIFE (QOL) IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)
Abstract
Authors
SC Bonicatto
SC Bonicatto
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now